TY - JOUR
T1 - Pulmonary rehabilitation in sarcoidosis
T2 - A systematic review and meta-analysis
AU - Alsina-Restoy, Xavier
AU - Torres-Castro, Rodrigo
AU - Caballería, Estrella
AU - Gimeno-Santos, Elena
AU - Solis-Navarro, Lilian
AU - Francesqui, Joel
AU - Hernández-Gonzalez, Fernanda
AU - Ramos-Casals, Manel
AU - Blanco, Isabel
AU - Sellarés, Jacobo
N1 - Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/11/1
Y1 - 2023/11/1
N2 - Background: Exercise intolerance, muscle weakness, dyspnoea, and fatigue are frequent complications in symptomatic sarcoidosis patients. Pulmonary rehabilitation improves exercise capacity, symptoms, and quality of life in patients with chronic respiratory diseases. Our objective was to systematically determine the effects of pulmonary rehabilitation in patients with sarcoidosis. Methods: A systematic review was conducted in seven databases. Studies that applied pulmonary rehabilitation in patients with sarcoidosis were reviewed. Two independent reviewers analysed the studies, extracted the data and assessed the quality of evidence. Results: Of the 406 reports returned by the initial search, five articles reporting on 184 patients were included in the data synthesis. Two studies included multi-component exercise, one inspiratory muscle training, one a physical activity incentivisation programme, and one a telerehabilitation program. In the intervention group (IG), we found significant improvement in exercise capacity (SMD 1.65, 95%CI 0.45, 2.86 points, p = 0.006). If we only analyse the studies that performed the 6-min walking test, the IG walked 40.3 (CI95% 20.3, 60.2) m higher than the control group (CG) (p < 0.001). Additionally, dyspnoea score was reduced (MD -0.42 95%CI -0.75, −0.10, p = 0.002). However, fatigue, quality of life and pulmonary function did not show any change. Conclusion: Pulmonary rehabilitation could improve exercise capacity and dyspnoea perception in patients with sarcoidosis.
AB - Background: Exercise intolerance, muscle weakness, dyspnoea, and fatigue are frequent complications in symptomatic sarcoidosis patients. Pulmonary rehabilitation improves exercise capacity, symptoms, and quality of life in patients with chronic respiratory diseases. Our objective was to systematically determine the effects of pulmonary rehabilitation in patients with sarcoidosis. Methods: A systematic review was conducted in seven databases. Studies that applied pulmonary rehabilitation in patients with sarcoidosis were reviewed. Two independent reviewers analysed the studies, extracted the data and assessed the quality of evidence. Results: Of the 406 reports returned by the initial search, five articles reporting on 184 patients were included in the data synthesis. Two studies included multi-component exercise, one inspiratory muscle training, one a physical activity incentivisation programme, and one a telerehabilitation program. In the intervention group (IG), we found significant improvement in exercise capacity (SMD 1.65, 95%CI 0.45, 2.86 points, p = 0.006). If we only analyse the studies that performed the 6-min walking test, the IG walked 40.3 (CI95% 20.3, 60.2) m higher than the control group (CG) (p < 0.001). Additionally, dyspnoea score was reduced (MD -0.42 95%CI -0.75, −0.10, p = 0.002). However, fatigue, quality of life and pulmonary function did not show any change. Conclusion: Pulmonary rehabilitation could improve exercise capacity and dyspnoea perception in patients with sarcoidosis.
KW - Dyspnoea
KW - Exercise capacity
KW - Fatigue
KW - Pulmonary rehabilitation
KW - Quality of life
KW - Sarcoidosis
UR - http://www.scopus.com/inward/record.url?scp=85175566463&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2023.107432
DO - 10.1016/j.rmed.2023.107432
M3 - Article
C2 - 37858728
AN - SCOPUS:85175566463
SN - 0954-6111
VL - 219
JO - Respiratory Medicine
JF - Respiratory Medicine
M1 - 107432
ER -